A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly

Wing, Lindon M.H., Reid, Christopher M., Ryan, Philip, Beilin, Lawrence J., Brown, Mark A., Jennings, Garry L.R., Johnston, Colin I., McNeil, John J. +4 more·2003·New England Journal of Medicine

Cited by (1,000)

Items 101–200 of 1,000

  1. Coenzyme Q10 in cardiovascular disease
    Salvatore Pepe, Silvana Marasco, Steven Joseph Haas, Freya L. Sheeran, Henry Krum, Franklin Rosenfeldt · 2007 · Mitochondrion
  2. Moderated ePoster Session 2
    Javed Butler, CARINE E. HAMO, Gerasimos S Filippatos, Stuart Pocock, Richard A. Bernstein, Martina Brueckmann, Alfred K. Cheung, Jyothis Thomas George, Jennifer B. Green, James L. Januzzi et al. · 2014 · European Journal of Heart Failure
  3. Isolated Systolic Hypertension in the Elderly
    Aram V. Chobanian · 2007 · New England Journal of Medicine
  4. Increased Framingham Coronary Heart Disease Risk Score in Dementia Caregivers Relative to Non-Caregiving Controls
    von Känel, Roland, Mausbach, Brent T., Patterson, Thomas L., Dimsdale, Joel E., Aschbacher, Kirstin, Mills, Paul J., Ziegler, Michael G., Ancoli-Israel, Sonia, Grant, Igor · 2008 · Gerontology
  5. Different Effects of Antihypertensive Regimens Based on Fosinopril or Hydrochlorothiazide With or Without Lipid Lowering by Pravastatin on Progression of Asymptomatic Carotid Atherosclerosis
    Alberto Zanchetti, Gaetano Crepaldi, M. Gene Bond, Giuseppe Gallus, Fabrizio Veglia, Giuseppe Mancia, Alessandro Ventura, Giovannella Baggio, Lorena Sampieri, Paolo Rubba et al. · 2004 · Stroke
  6. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
    Wilbert S. Aronow, Jerome L. Fleg, Carl J. Pepine, Nancy T. Artinian, George L. Bakris, Alan S. Brown, Keith C. Ferdinand, Mary Ann Forciea, William H. Frishman, Cheryl S. Jaigobin et al. · 2011 · Journal of the American Society of Hypertension
  7. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
    Guy De Backer, Giuseppe Ambrosio, Knut Borch‐Johnsen, Carlos Brotons, Renata Cífková, Jean Dallongeville, Shah B J Ebrahim, Ole Færgeman, Ian D. Graham, Giuseppe Mancia et al. · 2003 · PubMed
  8. Effect of Inhibition of the Renin-Angiotensin System on Development of Type 2 Diabetes Mellitus (Meta-Analysis of Randomized Trials)
    Richard Andraws, David L. Brown · 2007 · The American Journal of Cardiology
  9. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The value randomised trial
    Stevo Julius, Sverre Erik Kjeldsen, Michael A. Weber · 2004 · ACC Current Journal Review
  10. Morbidity and Mortality of Orthostatic Hypotension: Implications for Management of Cardiovascular Disease
    Luke J. Benvenuto, Lawrence R. Krakoff · 2010 · American Journal of Hypertension
  11. Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach
    James Henry O’Keefe, Maia D. Carter, Carl J. Lavie · 2009 · Mayo Clinic Proceedings
  12. Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause
    Roger A. Lobo, James H. Pickar, John C. Stevenson, Wendy Jean Mack, Howard Neil Hodis · 2016 · Atherosclerosis
  13. Management of Uncontrolled Hypertension in a Nurse-Led Clinic Compared With Conventional Care for Patients with Type 2 Diabetes
    E. Denver, Maria Barnard, Robin G. Woolfson, Kenneth Earle · 2003 · Diabetes Care
  14. Diuretics for Hypertension: A Review and Update
    Roush, George C., Sica, Domenic A. · 2016 · American Journal of Hypertension
  15. Thiazide Effects and Adverse Effects
    David H. Ellison, Johannes Loffing · 2009 · Hypertension
  16. Role of Diuretics in the Prevention of Heart Failure
    Barry R. Davis, Linda B. Piller, Jeffrey A. Cutler, Curt Daniel Furberg, Kay Dunn, Stanley S. Franklin, David Calvin Goff, Frans H. H. Leenen, Syed Mohiuddin, Vasilios Papademetriou et al. · 2006 · Circulation
  17. Blockade of the Angiotensin II Type 1 Receptor Stabilizes Atherosclerotic Plaques in Humans by Inhibiting Prostaglandin E 2 –Dependent Matrix Metalloproteinase Activity
    Francesco Cipollone, Maria Luigia Fazia, Annalisa Iezzi, Barbara Pini, Chiara Cuccurullo, Mirco Zucchelli, Domenico De Cesare, Sante Ucchino, Francesco Spigonardo, Mariella De Luca et al. · 2004 · Circulation
  18. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trialThe first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension
    Kenneth Jamerson, George L. Bakris, C. C. Wun, Björn Dahlöf, Martin P. Lefkowitz, S Manfreda, Bertram Pitt, Eric J. Velazquez, Michael A. Weber · 2004 · American Journal of Hypertension
  19. Effects of Thiazide-Type and Thiazide-Like Diuretics on Cardiovascular Events and Mortality
    Rik Olde Engberink, Wijnanda J. Frenkel, Bas van den Bogaard, Lizzy M. Brewster, Liffert Vogt, Bert‐Jan H. van den Born · 2015 · Hypertension
  20. Hypertension in Blacks
    John David Spence, Brian Lindsay Rayner · 2018 · Hypertension
  21. Treatment of Hypertension in Patients With Coronary Artery Disease
    Clive Rosendorff, Daniel T. Lackland, Matthew Allison, Wilbert S. Aronow, Henry R. Black, Roger Scott Blumenthal, Christopher Paul Cannon, James A. de Lemos, W.J. Elliott, Laura Findeiss et al. · 2015 · Journal of the American College of Cardiology
  22. Monitoring global health: time for new solutions
    Christopher J L Murray, Alan D López, Suwit Wibulpolprasert · 2004 · BMJ
  23. Development of heart failure in recent hypertension trials
    Giuliano Tocci, Sebastiano Sciarretta, Massimo Volpe · 2008 · Journal of Hypertension
  24. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study
    James M. Peacock, Tetsuya Ohira, Wendy S. Post, Nona Sotoodehnia, Wayne D. Rosamond, Aaron R. Folsom · 2010 · American Heart Journal
  25. Chronic Management of Blood Pressure After Stroke
    Pedelty, Laura, Gorelick, Philip B. · 2004 · Hypertension
  26. Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung (DGK)
    Rainer Dietz, Bernhard Rauch · 2003 · Zeitschrift für Kardiologie
  27. Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients
    Michael H. Alderman · 2003 · American Journal of Hypertension
  28. 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
    2022 · PubMed Central
  29. The past, present and future of renin–angiotensin aldosterone system inhibition
    Robert John Mentz, George L. Bakris, Bernard Waeber, John J.V. McMurray, Mihai Gheorghiade, Luis Miguel Ruilope, Aldo Pietro Maggioni, Karl B Swedberg, Ileana L. Piña, Mona Fiuzat et al. · 2012 · International Journal of Cardiology
  30. Meta-Analysis of Dose-Response Characteristics of Hydrochlorothiazide and Chlorthalidone: Effects on Systolic Blood Pressure and Potassium
    Michael E. Ernst, Barry L. Carter, S. Zheng, Richard H. Grimm · 2010 · American Journal of Hypertension
  31. Renin-Angiotensin System and Atherothrombotic Disease
    Douglas S. Jacoby, Daniel James Rader · 2003 · Archives of Internal Medicine
  32. Cerebroprotection mediated by angiotensin II
    Albert E. Fournier, Franz H. Messerli, Jean Michel Achard, Leonardo A. Fernandez · 2004 · Journal of the American College of Cardiology
  33. RAS inhibition in hypertension
    Ibrahim, M Mohsen · 2006 · Journal of Human Hypertension
  34. Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?
    Alberto Zanchetti · 2009 · Journal of Hypertension
  35. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome
    Mahmut İlker Yılmaz, Alper Sönmez, Kayser Çağlar, Turgay Celık, Müjdat Yenicesu, Tayfun Eyileten, Cengizhan Açıkel, Yusuf Oğuz, İzzet Yavuz, Abdülgaffar Vural · 2007 · Nephrology
  36. ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses
    Jackson T. Wright · 2009 · Archives of Internal Medicine
  37. Nigella sativaand Its Protective Role in Oxidative Stress and Hypertension
    Xin-Fang Leong, Mohd Rais Mustafa, Kamsiah Jaarin · 2013 · Evidence-based Complementary and Alternative Medicine
  38. Atorvastatin Prevents End-Organ Injury in Salt-Sensitive Hypertension
    Ming-Sheng Zhou, Edgar A. Jaimes, Leopoldo R. Raij · 2004 · Hypertension
  39. Overcome Clinical Inertia to Control Systolic Blood Pressure
    Patrick J. O’Connor · 2003 · Archives of Internal Medicine
  40. Recent hypertension trials
    Bryan Williams · 2005 · Journal of the American College of Cardiology
  41. Self‐reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2)
    Mark Raymond Nelson, Christopher Michael Reid, Philip Ryan, Kristyn J. Willson, Lisa Nicole Yelland · 2006 · The Medical Journal of Australia
  42. Validation of a new formula for mean arterial pressure calculation: The new formula is superior to the standard formula
    Mansour Razminia, Atul Trivedi, János Molnár, Monther Elbzour, Mayra E Guerrero, Yasser Salem, Aziz Ahmed, Sandeep Khosla, David L. Lubell · 2004 · Catheterization and Cardiovascular Interventions
  43. Users' guide to detecting misleading claims in clinical research reports
    Montori, Victor M, Jaeschke, Roman, Schünemann, Holger J, Bhandari, Mohit, Brozek, Jan L, Devereaux, P J, Guyatt, Gordon H · 2004 · BMJ
  44. Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients
    E. Chowdhury, Alice J. Owen, Henry Krum, Lindon M H Wing, Mark Raymond Nelson, Christopher Michael Reid · 2013 · Journal of Hypertension
  45. Initial Treatment of Hypertension
    Phyllis August · 2003 · New England Journal of Medicine
  46. Hypertension in women
    Michel E. Safar · 2003 · American Journal of Hypertension
  47. Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial
    Simon Stewart, Melinda Jane Carrington, C. Swemmer, Craig S. Anderson, Nicol Kurstjens, John V. Amerena, Alex D. H. Brown, Louise M. Burrell, Ferdinandus J. de Looze, Mark Harris et al. · 2012 · BMJ
  48. Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide
    Michael E. Ernst, Michelle A. Fravel · 2022 · American Journal of Hypertension
  49. Barriers to cardiovascular disease risk scoring and primary prevention in Europe
    Richard F. Hobbs, J. Wouter Jukema, P. M. Da Silva, Terry McCormack, Alberico Luigi Catapano · 2010 · QJM
  50. Cost-Effectiveness of Ambulatory Blood Pressure
    Lawrence R. Krakoff · 2005 · Hypertension
  51. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
    Emma Copland, Dexter Canoy, Milad Nazarzadeh, Zeinab Bidel, Rema Ramakrishnan, Mark Woodward, John Philip Chalmers, Koon Kang Teo, Carl J. Pepine, Barry R. Davis et al. · 2021 · The Lancet Oncology
  52. The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension
    James M. Mason, Heather Olivia Dickinson, Donald J Nicolson, Fiona Campbell, Gary A. Ford, Bryan Williams · 2005 · Journal of Hypertension
  53. Gender Differences in Cardiovascular Pharmacotherapy—the Example of Hypertension: A Mini Review
    Jacklean Kalibala, Antoinette Péchère-Bertschi, Jules Alexandre Desmeules · 2020 · Frontiers in Pharmacology
  54. Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
    Robert M. Califf, Mitradev Boolell, Steven M. Haffner, Mary Angelyn Bethel, John J.V. McMurray, Anil Duggal, Rury R. Holman · 2008 · American Heart Journal
  55. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure – meta-analyses of randomized trials
    Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2016 · Journal of Hypertension
  56. Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol
    Jorge R. Kizer, Björn Dahlöf, Sverre Erik Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister J. Kristianson, Ole Lederballe‐Pedersen et al. · 2004 · Hypertension
  57. Timeline of History of Hypertension Treatment
    Saklayen, Mohammad G., Deshpande, Neeraj V. · 2016 · Frontiers in Cardiovascular Medicine
  58. Hypertension in women
    Eduardo Pimenta · 2011 · Hypertension Research
  59. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality
    Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2018 · Journal of Hypertension
  60. Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases
    Bruna Visniauskas, Isabella Kilanowski‐Doroh, Benard Ojwang Ogola, Alexandra B. McNally, Alec C. Horton, Ariane Imulinde Sugi, Sarah Hoffmann Lindsey · 2022 · Journal of Human Hypertension
  61. Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study
    Walter Zidek, Joachim Schrader, Stephan Lüders, Stephan Matthaei, Christoph Hasslacher, Joachim D. Hoyer, Claudia Zemmrich, Peter Bramlage, Claus‐Dieter Sturm, W. Dieter Paar · 2012 · Cardiovascular Diabetology
  62. Hypertension: Pathophysiology and Treatment
    Sinny Delacroix, Ramesh G. Chokka · 2014 · Journal of Neurology & Neurophysiology
  63. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
    Atle Fretheim, Jan Odgaard‐Jensen, Odd Brørs, Steinar Madsen, Inger Njølstad, Ole Frithjof Norheim, Arne Svilaas, Ivar S. Kristiansen, Hanne L. Thürmer, Signe Agnes Flottorp · 2012 · BMC Medicine
  64. Risk of Thiazide-induced Hyponatremia in Patients with Hypertension
    Alexander A. C. Leung, Adam T. Wright, Valeria Pazo, Andrew S. Karson, David Westfall Bates · 2011 · The American Journal of Medicine
  65. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality
    Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2018 · Journal of Hypertension
  66. Hypertension in women: latest findings and clinical implications
    Helga Gudmundsdottir, Aud Høieggen, Aud E. Stenehjem, Bård Waldum, Ingrid Os · 2012 · Therapeutic Advances in Chronic Disease
  67. A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): a randomized controlled trial
    Carl J. Pepine, Eileen Mary Handberg, R COOPERDEHOFF · 2004 · ACC Current Journal Review
  68. The Story of the Silent Killer
    Jonathan P. Kalehoff, Suzanne Oparil · 2020 · Current Hypertension Reports
  69. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
    Yu Jie Chen, Liang Jin Li, Wen Lu Tang, Jia Yang Song, Ru Qiu, Qian Li, Hao Xue, James M Wright · 2018 · Cochrane Database of Systematic Reviews
  70. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension
    Sverre Erik Kjeldsen · 2004 · Heart Drug
  71. RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
    Thomas G. von Lueder, Henry Krum · 2012 · Cardiovascular Drugs and Therapy
  72. Hypertensive nephropathy: prevention and treatment recommendations
    Peter D Hart, George L. Bakris · 2010 · Expert Opinion on Pharmacotherapy
  73. Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics
    Juan Luis Tamargo, J. Segura, Luis Miguel Ruilope · 2014 · Expert Opinion on Pharmacotherapy
  74. COX-2 and Atherosclerosis
    Francesco Cipollone, Maria Luigia Fazia · 2006 · Journal of Cardiovascular Pharmacology
  75. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis
    Paolo Verdecchia, Fabio Angeli, C. Cavallini, Roberto Gattobigio, Giorgio Gentile, Jan A. Staessen, Gianpaolo Reboldi · 2008 · European Heart Journal
  76. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT
    JohnH. Laragh · 2003 · American Journal of Hypertension
  77. Thiazide Diuretics in the Treatment of Hypertension
    Antonio Salvetti, Lorenzo Ghiadoni · 2006 · Journal of the American Society of Nephrology
  78. Is Angiotensin II a Direct Mediator of Left Ventricular Hypertrophy?
    Timothy L. Reudelhuber, Kenneth E. Bernstein, Patrice Delafontaine · 2007 · Hypertension
  79. Association Between Chlorthalidone Treatment of Systolic Hypertension and Long-term Survival
    John B. Kostis, Javier Cabrera, Jerry Cheng, Nora M. Cosgrove, Yingzi Deng, Sara Pressel, Barry R. Davis · 2011 · JAMA
  80. Treatment of hypertension in patients with coronary artery disease
    Clive Rosendorff, Daniel T. Lackland, Matthew Allison, Wilbert S. Aronow, Henry R. Black, Roger Scott Blumenthal, Christopher Paul Cannon, James A. de Lemos, W.J. Elliott, Laura Findeiss et al. · 2015 · Journal of the American Society of Hypertension
  81. Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007
    Grupo de Trabajo para el Tratamiento de la Hipertensión Arterial de la Sociedad Europea de Hipertensión (ESH), de la Sociedad Europea de Cardiología · 2007 · Revista Española de Cardiología
  82. Effects of antihypertensive treatment in patients over 65 years of age: a meta-analysis of randomised controlled studies
    Αlexandros Briasoulis, Vikram Agarwal, Dimitris Tousoulis, Christodoulos Stefanadis · 2013 · Heart
  83. Lowering blood pressure for cardiovascular risk reduction
    Gordon T. McInnes · 2005 · Journal of Hypertension
  84. Diabetes and the Risk of Heart Failure
    Ravi Dhingra, Ramachandran Srini Vasan · 2011 · Heart Failure Clinics
  85. Small artery remodelling in hypertension: causes, consequences and therapeutic implications
    Michael John Mulvany · 2008 · Medical & Biological Engineering & Computing
  86. Prevention of Stroke in Patients with Hypertension
    Björn Dahlöf · 2007 · The American Journal of Cardiology
  87. The renin-angiotensin system and insulin resistance
    Zhenqi Liu · 2007 · Current Diabetes Reports
  88. Race and Ethnicity in Trials of Antihypertensive Therapy to Prevent Cardiovascular Outcomes: A Systematic Review
    I. U. Park, Anne L. Taylor · 2007 · The Annals of Family Medicine
  89. Cardiology: the past, the present, and the future
    Eugene Braunwald · 2003 · Journal of the American College of Cardiology
  90. Large‐Artery Stiffness Contributes to the Greater Prevalence of Systolic Hypertension in Elderly Women
    Karen L. Berry, James D. Cameron, Anthony Michael Dart, Elizabeth M. Dewar, Christoph D. Gatzka, Garry Jennings, Yu‐Lu Liang, Christopher Michael Reid, Bronwyn A. Kingwell · 2004 · Journal of the American Geriatrics Society
  91. Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly
    Mark Raymond Nelson, Christopher Michael Reid, Lawrence Joseph Beilin, Geoffrey Alan Donnan, Colin I. Johnston, Henry Krum, Elsdon Storey, Andrew Maxwell Tonkin, John J. McNeil · 2003 · Drugs & Aging
  92. Impact of the ALLHAT/JNC7 Dissemination Project on Thiazide-Type Diuretic Use
    Randall Scott Stafford · 2010 · Archives of Internal Medicine
  93. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension
    Hidefumi Fukunaga, Takayoshi Ohkubo, Makoto Kobayashi, Yuichiro Tamaki, Masahiro Kikuya, Taku Obara, Miwa Nakagawa, Azusa Hara, Kei Asayama, Hirohito Metoki et al. · 2008 · Journal of Hypertension
  94. Milk-Derived Peptides, Val-Pro-Pro and Ile-Pro-Pro, Attenuate Atherosclerosis Development in Apolipoprotein E–Deficient Mice: A Preliminary Study
    Teppei Nakamura, Tatsuhiko Hirota, Katsura Mizushima, Kohji Ohki, Yuji Naito, Naoyuki Yamamoto, Toshikazu Yoshikawa · 2013 · Journal of Medicinal Food
  95. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
    Hao Xue, Zhuang Lu, Wen Lu Tang, Lu Wei Pang, Gan Mi Wang, Gavin WK Wong, James M Wright · 2015 · Cochrane Database of Systematic Reviews
  96. Blood pressure as an example of a biomarker that functions as a surrogate
    Mehul G. Desai, Norman Stockbridge, Robert Temple · 2006 · The AAPS Journal
  97. The Evidence-Based Use of Thiazide Diuretics in Hypertension and Nephrolithiasis
    Robert F. Reilly, Aldo J. Peixoto, Gary V. Désir · 2010 · Clinical Journal of the American Society of Nephrology
  98. Feasibility of conducting a primary prevention trial of low‐dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study
    Mark R Nelson, Christopher Michael Reid, David J. Ames, Lawrence Joseph Beilin, Geoffrey Alan Donnan, Peter Gibbs, Colin I. Johnston, Henry Krum, Elsdon Storey, Andrew Maxwell Tonkin et al. · 2008 · The Medical Journal of Australia
  99. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension
    Sverre Erik Kjeldsen · 2004 · Heart Drug
  100. Costs of Inpatient Care Among Medicare Beneficiaries With Heart Failure, 2001 to 2004
    David J. Whellan, Melissa A. Greiner, Kevin Alan Schulman, Lesley H. Curtis · 2009 · Circulation Cardiovascular Quality and Outcomes